The Trump administration has named Richard Pazdur, a longtime oncology expert at the Food and Drug Administration, as the nation’s top drug regulator.
Pazdur will lead the agency’s Center for Drug Evaluation and Research, which regulates over-the-counter medicines and most prescription drugs. He replaces George Tidmarsh, who federal officials say resigned over a week ago after being placed on leave over allegations that he misused his authority, in a tumultuous period for the FDA.
